B
Cannara Biotech Inc. LOVE.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

05/31/2025 02/28/2025 11/30/2024 08/31/2024 05/31/2024
Net Income 182.88% 109.88% -28.60% -9.91% 6.93%
Total Depreciation and Amortization 2.25% 11.34% 15.68% 27.19% 22.49%
Total Amortization of Deferred Charges -65.08% -65.08% -79.77% -92.29% 37.00%
Total Other Non-Cash Items -84.79% -181.56% 390.93% 175.27% 1,342.19%
Change in Net Operating Assets 51.93% 14.05% 128.94% 65.43% 63.91%
Cash from Operations 84.08% 19.35% 141.19% 99.05% 1,601.49%
Capital Expenditure 40.57% 25.68% 33.47% 25.15% 33.41%
Sale of Property, Plant, and Equipment -98.66% 1,618.27% 1,080.82% 994.43% 2,591.91%
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 23.59% 20.39% -9.64% -23.32% -10.78%
Cash from Investing 22.12% 51.79% 57.40% 45.77% 50.48%
Total Debt Issued -93.06% -58.46% -32.73% 90.00% -82.36%
Total Debt Repaid 35.00% -98.67% -115.95% -107.99% 80.43%
Issuance of Common Stock -- -- -- -- -100.00%
Repurchase of Common Stock 100.00% 100.00% 99.34% 25.99% -180.99%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 25.13% 42.57% 21.93% -1.73% -39.29%
Cash from Financing -104.91% -135.73% -114.59% 7.68% -120.81%
Foreign Exchange rate Adjustments -- -- -- -- 100.00%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 510.47% 314.47% 283.40% 129.71% 171.46%